Table 4. Treatment initiation status of bacteriologically confirmed rifampicin sensitive TB cases.

Variables	Total	Initiated treatment	% (95% CI)	Died	% (95% CI)	Lost to follow-up	% (95% CI)	Transferred Out	% (95% CI)	NA	% (95% CI)
Overall	3045	2738	89.9 (88.8–90.9)	60	2.0 (1.5–2.5)	118	3.9 (3.2–4.6)	6	0.2 (0.1–0.5)	123	4.0 (3.4–4.8)
Age
0–4	639	523	81.9 (78.6–84.7)	32	5.0 (3.6–7.0)	39	6.1 (4.4–8.3)	2	0.3 (0.1–1.3)	43	6.7 (5.0–9.0)
5–9	685	620	90.5 (88.0–92.6)	13	2.0 (1.1–3.3)	22	3.2 (2.1–4.9)	0		30	4.4 (3.0–6.3)
10–14	1721	1595	92.7 (91.3–93.8)	15	0.9 (0.5–1.5)	57	3.3 (2.5–4.3)	4	0.2 (0.1–0.6)	50	2.9 (2.2–3.9)
Gender
Female	1871	1689	90.3 (88.8–91.6)	38	2.0 (1.5–2.8)	69	3.7 (2.9–4.7)	1	0.1 (0–0.03)	74	4.0 (3.1–5.0)
Male	1174	1049	89.4(87.4–91.0)	22	1.9 (1.2–2.9)	49	4.2 (3.1–5.5)	5	0.4 (0.2–1.1)	49	4.2 (3.1–5.5)
Sector
Private	281	260	92.5 (88.6–95.2)			11	3.9 (2.2–7.1)	1	0.4 (0.1–2.3)	9	3.2 (1.6–6.2)
Public	2764	2478	89.7 (88.4–90.8)	60	2.2 (1.7–2.8)	107	3.9 (3.2–4.7)	5	0.2 (0.1–0.5)	114	4.1 (3.4–5.0)

NA- not available